• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Antibiotics Prescribing & Optimisation
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • EMIS: GLP-1 NHS Obesity Programme (Tirzepatide)
      • Specialties
        • EMIS: Cardiovascular Disease Prevention & Management
        • EMIS: Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
        • EMIS: Cancer
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS: Palliative Care and End of Life
        • Chronic Kidney Disease (CKD) – EMIS
        • EMIS Renal Overview
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration & Governance
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • SystmOne: Suspected Cancer Referral
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • SystmOne: Infections
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Ophthalmology
        • Palliative Care and End of Life
        • Chronic Kidney Disease (CKD)
        • Respiratory Resources
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • SystmOne: Pneumococcal Vaccination
        • RSV Vaccination SystmOne
        • Shingles Vaccination
  • FAQs
  • News
    • Demonstrations
    • Recordings
    • Conference abstracts
  • Contact us
You are here: Home / Resources / EMIS Resource Centre / EMIS Specialties / EMIS: Cardiovascular Disease Prevention & Management

EMIS: Cardiovascular Disease Prevention & Management

The CDRC CVD Prevention and Management Resource Suite supports GP practices to systematically identify, assess and manage patients who may have established cardiovascular disease or be at increased risk of developing cardiovascular disease.

The resource suite combines:

  • CDRC Reports for population-level case finding, clinical prioritisation and quality improvement.
  • The CDRC Precision CVD Prevention Template for individual patient assessment, coding and management.
  • A patient-level alert highlighting relevant CVD prevention information within the EMIS record.
  • Clinical decision support covering cardiovascular risk, blood pressure, lipids, atrial fibrillation, chronic kidney disease, weight and glycaemic control

Together, these resources provide a structured pathway from population-level identification to individual patient review, clinical action and follow-up. The Population Reporting suite currently includes searches covering Atrial Fibrillation, Coronary Heart Disease, Heart Failure, Hypertension, PAD, Medication Optimisation and drugs prescribed without a corresponding diagnosis

Accessing the CDRC Resources

Accessing the CDRC Reports

CDRC Population Reporting searches are provided directly by the CDRC team. This helps ensure practices receive the appropriate and most current version of the searches, together with any necessary implementation support.

To request access, please email contact-cdrc@healthinnovationnenc.org.uk and a member of the CDRC team will will provide information about access and available support.

This is a temporary arrangement while CDRC develops an enhanced EMIS support service offering improved resource access, regular updates and ongoing support for participating practices.

Accessing the CDRC Precision Resource Launcher

The CDRC Precision Resource Launcher must be enabled at the practice before the CVD Prevention Template can be opened.

For installation and access guidance, visit: Accessing the CDRC Resource Launcher

Accessing the CDRC Precision Resource Launcher

Once enabled, the template can be opened from:

CDRC Precision Resource Launcher → Assessment and Management Templates → Cardiovascular → Precision CVD Prevention


CDRC Cardiovascular Reports

The CDRC Cardiovascular reports support the identification and management of patients with diagnosed or potentially undiagnosed cardiovascular disease. The structure of this report folder is broken down into condition areas.

Atrial Fibrillation

The Atrial Fibrillation reports support screening, case finding and the management of patients with recorded or possible atrial fibrillation. [cdrc.nhs.uk]

The reports may support practices to:

  • Identify patients who may require assessment for AF
  • Review patients with an existing AF diagnosis
  • Identify potential coding gaps
  • Prioritise patients who may require a structured AF review
  • Support review of stroke and bleeding risk information
  • Identify opportunities to review treatment
Coronary Heart Disease (CHD)

The Coronary Heart Disease reports include case-finding searches designed to support the identification and coding of patients with possible CHD. [cdrc.nhs.uk]

Suggested practice action

For each identified patient:

  1. Review the patient’s diagnoses and cardiovascular history.
  2. Review relevant correspondence, investigation results and procedures.
  3. Determine whether the clinical record supports a CHD diagnosis.
  4. Correct or add clinical coding where appropriate.
  5. Review cardiovascular prevention and medication management.
  6. Arrange further assessment where the diagnosis remains uncertain.
  7. Record the outcome and follow-up plan
Heart Failure

The Heart Failure reports support case finding and management, including the identification of patients who may require review of their diagnosis, coding or current management.

Hypertension

The Hypertension reports support screening, case finding and management of patients with recorded or possible hypertension. The existing reporting guidance recommends reviewing identified patients, repeating blood pressure measurements, updating disease coding and optimising treatment where appropriate.

Use the dedicated blood-pressure page within the CVD Prevention Template to support structured assessment and recording.

Medication

The Medication Concordance reports support the identification of patients whose prescribing or medication record may indicate that a treatment review is required.

The Drugs to Diagnosis reports help identify patients receiving medication without an expected corresponding diagnosis in the clinical record. [cdrc.nhs.uk]

A report result may reflect:

  • Missing or incomplete diagnosis coding
  • Treatment initiated for another indication
  • Historic medication that requires review
  • Information recorded elsewhere in the clinical record
  • A genuine need for further diagnostic assessment

The Specific Medications reports support safe prescribing by identifying patients who may have a medication-related safety risk or whose current treatment may require review to determine whether a safer alternative is appropriate.

PAD

The Peripheral Arterial Disease reports support case finding, coding review and safer prescribing for patients with recorded or potential peripheral arterial disease.

The reports identify patients who may have:

  • Medication associated with peripheral arterial disease without a corresponding PAD diagnosis
  • A PAD diagnosis code without the relevant QOF code
  • A recorded PAD diagnosis where antiplatelet treatment may require consideration
Stroke / TIA

The Stroke and Transient Ischaemic Attack reports support case finding, coding review and safer prescribing for patients with a recorded or potential history of stroke or transient ischaemic attack.

The reports identify patients who may have:

  • A potential indicator of stroke or transient ischaemic attack without a corresponding QOF diagnosis code
  • Vascular dementia codes without a recorded history of stroke or transient ischaemic attack
  • A recorded stroke where the stroke type has not been classified
  • Ischaemic or unclassified stroke where antiplatelet treatment may require consideration

CDRC Precision: CVD Prevention PSA


When a patient record is opened, the CDRC Precision: CVD Prevention alert will appear where relevant. Hover over the alert to view key cardiovascular prevention information, as shown below.

The alert can support both consultation-based care and planned patient record reviews. Review the information alongside the patient’s full clinical record before deciding whether further assessment or action is required.


CDRC Precision CVD Prevention Template

The CDRC Precision CVD Prevention Template supports structured assessment and management across multiple areas of cardiovascular prevention.

The template:

  • Responds to coded information held in the patient record
  • Presents relevant prompts and clinical information
  • Supports consistent clinical coding
  • Highlights applicable quality indicators and guidance
  • Can be used alongside the CDRC Population Reporting resources
  • Brings several CVD prevention areas into a single patient review workflow [cdrc.nhs.uk]

Opening the Template

  1. Open the patient’s EMIS record.
  2. Press F12.
  3. Select CDRC Precision Resource Launcher.
  4. Select OK.
  5. Open Assessment and Management Templates.
  6. Select Cardiovascular.
  7. Open Precision CVD Prevention.

Template Pages

Core Data Entry

The Core Data Entry page supports the recording of information including:

  • Mobility
  • Smoking
  • Alcohol
  • Depression and anxiety screening

The existing template page also contains prompts relating to applicable CVD indicators and supports accurate coding

Blood Pressure

The blood-pressure functionality supports:

  • Review and recording of blood-pressure information
  • Identification of applicable blood-pressure targets
  • Display of targets relevant to specific long-term conditions
  • Review of relevant quality indicators
  • Consistent clinical coding

Lipid Management

The Lipid Management page supports:

  • Review of current lipid results
  • Recording and calculation of non-HDL cholesterol targets
  • Assessment of whether the recorded target has been achieved
  • Identification of possible treatment optimisation
  • Review of statin prescribing and safety information
  • Consistent recording of relevant decisions

Weight Management

The Weight Management page supports:

  • Accurate recording of BMI
  • Review of relevant referral criteria
  • Access to additional weight-management resources
  • Signposting to locally available pathways

Atrial Fibrillation

The Atrial Fibrillation page supports:

  • Structured AF assessment
  • Review of relevant coded information
  • Calculation or review of CHA₂DS₂-VASc
  • Calculation or review of ORBIT bleeding risk
  • Consideration of anticoagulation
  • Accurate recording of the review

Chronic Kidney Disease

The Chronic Kidney Disease page supports:

  • Review and recording of CKD stage
  • Review of relevant renal results
  • Accurate clinical coding
  • Guidance relating to ACE inhibitor or angiotensin receptor blocker use according to urine ACR information

Glycaemic Control

The Glycaemic Control page presents information appropriate to patients with diabetes or non-diabetic hyperglycaemia.

The page supports:

  • Review of glycaemic control
  • Presentation of relevant coded clinical information
  • Identification of patients who may require further intervention
  • Access to relevant referral guidance
  • Signposting to programmes such as the NHS Diabetes Prevention Programme or DESMOND where appropriate

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2026 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}